CD34 and acute myeloid leukemia: To determine whether our 3D BM niche-like AML model confers a drug resistance pattern in primary AML cells similar to those observed in AML cell lines, CD34 + primary AML cells were 3D-cultured within our models and treated with the chemotherapy drug AraC, and cell viability was observed.